Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. Show more

1800 Aston Avenue, Carlsbad, CA, 92008, United States

Health Information Services
Healthcare
Start AI Chat

Market Cap

347M

52 Wk Range

$10.65 - $17.19

Previous Close

$13.05

Open

$12.86

Volume

211,092

Day Range

$12.30 - $13.24

Enterprise Value

338.6M

Cash

115.4M

Avg Qtr Burn

-8.459M

Insider Ownership

43.78%

Institutional Own.

38.82%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date